Published • loading... • Updated
Asymchem Completes Its First USFDA Pre-Approval Inspection (PAI) of the Tianjin 4 TIDES Manufacturing Site
Summary by The Manila Times
4 Articles
4 Articles
The Manila Times+2 Reposted by 2 other sources
Asymchem Completes its First USFDA Pre-Approval Inspection (PAI) of the Tianjin 4 TIDES Manufacturing Site
TIANJIN, China, Oct. 29, 2026 /PRNewswire/ -- Asymchem successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection (PAI) of Asymchem Life...
·Manila, Philippines (the)
Read Full Article
Asymchem Completes its First USFDA Pre-Approval Inspection (PAI) of the Tianjin 4 TIDES Manufacturing Site - Business News Week
TIANJIN, China, Oct. 29, 2026 /PRNewswire/ — Asymchem successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection (PAI) of Asymchem Life Science (Tianjin) Co., Ltd.’s TIDES development and manufacturing facility (“TJ4”), which took place between June 29th to July 2nd, 2026. This marks the first western regulatory agency inspection of the Tianjin […] The post Asymchem Completes its First USFDA Pre-Approval I…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
